Colin McCoin

Title: Colin McCoin: Innovator in Immunogenic Compositions

Introduction

Colin McCoin is a notable inventor based in Castro Valley, CA (US). He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions targeting Norovirus and Sapovirus. With a total of 5 patents, his work has the potential to impact public health significantly.

Latest Patents

Colin's latest patents focus on immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens. These inventions involve polynucleotides encoding capsid proteins or other immunogenic viral polypeptides from various strains of Norovirus and/or Sapovirus. His work includes the coexpression of these viral polypeptides with adjuvants and methods for their application in immunization and the production of viral-like particles (VLPs). Additionally, his patents describe methods for producing multiple epitope fusion antigens or polyproteins, which may also include antigens for immunization against other pathogens causing diarrheal diseases, such as rotavirus.

Career Highlights

Colin McCoin is currently associated with Novartis Vaccines & Diagnostics GmbH, where he continues to advance his research in immunology. His innovative work has positioned him as a key figure in the development of vaccines and diagnostic tools.

Collaborations

Colin has collaborated with notable colleagues, including Doris Guenzi Coit and Michael Houghton, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Colin McCoin's contributions to immunogenic compositions represent a significant advancement in the fight against viral pathogens. His innovative patents and collaborations highlight his commitment to improving public health through scientific research.